Therapy Areas: Central Nervous System
27 March 2020 - Saniona AB (STO:SANION), a clinical stage biopharmaceutical company focused on rare diseases of the central nervous system, announced on Thursday a new research collaboration with Boeh...
18 March 2020 - Biopharmaceutical company AbbVie (NYSE:ABBV) on Tuesday announced a consent decree agreement with staff of the US Federal Trade Commission (FTC) regarding the proposed acquisition of A...
11 March 2020 - - US-based biotechnology company ReAlta Life Sciences, Inc., has appointed Deborah Geraghty, Ph.D., chief operating officer of Anokion, and Azmi Nabulsi, M.D., M.P.H., chief operating ...
5 March 2020 - Pharmaceutical company Luye Pharma Group said on Wednesday that it has submitted its New Drug Application (NDA) for LY03005, a new chemical drug for the treatment of major depressive di...
26 February 2020 - - Canada-based specialty biotech pharmaceutical R and D company FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) has sold its 12% equity interest in Cannara Biotech Inc. ...
19 February 2020 - Saniona AB (STO:SANION), a clinical stage biotechnology company focused on rare diseases of the Central Nervous System, announced on Tuesday that Thomas Feldthus, co-founder and CFO...
Related Headlines